Breast-conserving therapy for ductal carcinoma in situ: A 20-year experience with excision plus radiation therapy

American Journal of Surgery

Volumn 184, Issue 5, 2002, Pages 403-409

  Nakamura, Shelley ^a   Woo, Carol ^a   Silberman, Howard ^a   Streeter Jr , Oscar E ^a   Lewinsky, Bernard S ^b   Silverstein, Melvin J ^a,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Western Tumor Medical Group   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Boost dose; Breast irradiation; Ductal carcinoma in situ; Local recurrence; Noninvasive breast cancer; Radiation therapy

Indexed keywords

ADULT; ARTICLE; BREAST CARCINOMA; BREAST SURGERY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DATA BASE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TUMOR NECROSIS;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COMBINED MODALITY THERAPY; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NECROSIS; NEOPLASM RECURRENCE, LOCAL; TREATMENT OUTCOME;

EID: 0036845461     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(02)01011-5     Document Type: Article

References (28)

1. Ernster V.L., Barclay J., Kerlikowske K., et al. Incidence and treatment for ductal carcinoma in situ of the breast. JAMA. 275:1996;913-918.
2. Sarrazin D., Le M.G., Arriagada R., et al. Ten year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol. 14:1989;177-184.
3. Fisher B., Anderson S. Conservative surgery for the management of invasive and noninvasive carcinomas of the breast NSABP trials . World J Surg. 18:1994;63-69.
4. Blichert-Toft M., Rose C., Anderson J.A., et al. Danish randomized trial comparing breast conservation therapy with mastectomy six years of life-table analysis . J Natl Cancer Inst Monogr. 11:1992;19-25.
5. Clarke D.H., Le M.G., Sarrazin D., et al. Analysis of local regional relapse in patients with early breast cancers treated by excision and radiotherapy experience of the Institut Gustave-Roussy . Int J Radiat Oncol Biol Phys. 11:1985;137-145.
6. Lichter A.S., Lippman M.E., Danforth D.N., et al. Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast a randomized trial at the National Cancer Institute . J Clin Oncol. 10:1992;976-983.
7. Veronesi U. Rationale and indications for limited surgery in breast cancer current data . World J Surg. 11:1987;493-498.
8. Fisher B., Costantino J., Redmond C., et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med. 328:1993;1581-1586.
9. Fisher B., Dignam J., Wolmark N., et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer findings from National Surgical Adjuvant Breast and Bowel Project B-17 . J Clin Oncol. 16:1998;441-452.
10. Fisher E.R., Constantino J., Fisher B., et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17 intraductal carcinoma (ductal carcinoma in situ) . Cancer. 75:1995;1310-1319.
11. Fisher E.R., Dignam J., Tan-Chiu E., et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17 intraductal carcinoma . Cancer. 86:1999;429-438.
12. Fisher B., Land S., Mamounas E., et al. Prevention of invasive breast cancer in women with ductal carcinoma in situ an update of the National Surgical Adjuvant Breast and Bowel Project Experience . Semin Oncol. 28:2001;400-418.
13. Julien J.P., Bijker N., Fentiman I., et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ first results of EORTC randomized phase III trial 10853 . Lancet. 355:2000;528-533.
14. Bijker N., Peterse J.L., Duchateau L., et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma in situ analysis of European Organization for Research and Treatment of Cancer Trial 10853 . J Clin Oncol. 19:2001;2263-2271.
15. George W.D., Houghton J., Cuzick J., et al. Radiotherapy and tamoxifen following complete local excision (CLE) in the management of ductal carcinoma in situ (DCIS) preliminary results from the UK DCIS trial . [abstract] Proc Am Soc Clin Oncol. 19:2000;70.
16. Houghton J., George W.D. Radiotherapy and tamoxifen after complete excision of ductal carcinoma in situ of the breast. Silverstein M.J., Recht A., Lagios M.D., Ductal carcinoma in situ of the breast. 2002;453-456 Lippincott, Williams and Wilkins, Philadelphia.
17. Kurtz J.M., Amalrick R., Brandone H., et al. How important is adequate radiotherapy for the long term results of breast-conserving treatment? Radiother Oncol. 20:1991;84.
18. Osborne M.P., Ormiston N., Harmer C.L., et al. Breast conservation in the treatment of early breast cancer. Cancer. 53:1984;349.
19. Solin L.J., Kurtz J., Fourquet A., et al. Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol. 14:1996;754-763.
20. Lagios M.D., Westdahl P.R., Margolin F.R., Rose M.R. Duct carcinoma in situ relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures . Cancer. 50:1982;1309-1314.
21. Lagios M.D., Margolin F.R., Westdahl P.R., Rose M.R. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer. 63:1989;618-624.
22. Silverstein M.J., Lagios M., Craig P., et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer. 77:1996;2267-2274.
23. Silverstein M.J., Lagios M.D., Groshen S., et al. The influence of margin width on local control in patients with ductal carcinoma in situ (DCIS) of the breast. N Engl J Med. 340:1999;1455-1461.
24. Ray G.R., Fish V.J. Biopsy and definitive radiation therapy in stage I and II adenocarcinoma of the female breast analysis of cosmesis and the role of electron beam supplementation . Int J Radiat Oncol Biol Phys. 9:1983;813.
25. Vicini F.A., White J., Gustafson G., et al. The use of Iodine-125 seeds as a substitute for Iridium-192 seeds in temporary interstitial breast implants. Int J Radiat Oncol Biol Phys. 27:1993;561-566.
26. Nobler M.P., Venet L. Prognostic factors in patients undergoing curative irradiation for breast cancer. Int J Radiat Oncol Biol Phys. 11:1985;1323-1331.
27. Van Limbergen E., van den Bogaert W., van der Schueren E., et al. Tumor excision and radiotherapy as primary treatment of breast cancer analysis of patient and treatment parameters and local control. Radiother Oncol. 8:1987;1-9.
28. Bartelink H., Collette L., Forquet A., et al. Impact of a boost of 16GY on the local control and cosmesis in patients with early breast cancer the EORTC "boost versus no boost" trial . Int J Rad Oncol Biol Phys. 48:(suppl):2000;111.